Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Julien Masliah-Planchon
Affiliation
Curie Institute Hospital Group
ORCID
Career Start Year
2008
Papers
107
H Index
29
Expertise
CM4AI Collaborator
Antoine Forget (CM4AI)
PMID
Paper Title
Journal Title
Published Year
38060262
Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants.
J Natl Cancer Inst
2024
37908048
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection.
Int J Cancer
2024
37748860
Mosaic <i>BRCA1</i> promoter methylation contribution in hereditary breast/ovarian cancer pedigrees.
J Med Genet
2024
34583948
Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort.
J Clin Pathol
2023
37863903
Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups.
Nat Commun
2023
37524406
First report of medulloblastoma in a patient with MUTYH-associated polyposis.
Neuropathol Appl Neurobiol
2023
37706251
Molecular characterisation of tumours of the lacrimal apparatus.
Histopathology
2023
37605896
Unusually Aggressive Actinic Keratosis of the Eyelid and Conjunctiva.
Acta Derm Venereol
2023
37605249
Diagnostic accuracy of a minimal immunohistochemical panel in at/rt molecular subtyping, correlated to dna-methylation profiling.
Acta Neuropathol Commun
2023
37452026
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers.
Nat Commun
2023
37014508
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.
Acta Neuropathol
2023
37013660
A sellar presentation of a WNT-activated embryonal tumor: further evidence of an ectopic medulloblastoma.
Acta Neuropathol Commun
2023
37379234
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.
Neuro Oncol
2023
37010111
Merkel cell carcinoma from renal transplant recipients are mostly MCPyV-negative and are frequently associated with squamous cell carcinomas or precursors.
J Eur Acad Dermatol Venereol
2023
36974006
Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh-frozen breast/ovarian tumor versus blood.
Clin Genet
2023
37402566
<i>MSH3</i>: a confirmed predisposing gene for adenomatous polyposis.
J Med Genet
2023
37305585
A new tumorgraft panel to accelerate precision medicine in prostate cancer.
Front Oncol
2023
37032353
The absence of CFHR3 and CFHR1 genes from the T2T-CHM13 assembly can limit the molecular diagnosis of complement-related diseases.
Eur J Hum Genet
2023
37263769
Adaptive nanopore sequencing to determine pathogenicity of <i>BRCA1</i> exonic duplication.
J Med Genet
2023
37029667
The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.
J Neurosurg
2023
36716416
Metastatic Malignant Perivascular Epithelioid Cell Tumors With Microsatellite Instability Within Lynch Syndrome Successfully Treated With Anti-PD1 Pembrolizumab.
JCO Precis Oncol
2023
36700131
Identification of a large intra-exonic deletion in <i>BRCA2</i> exon 18 in a pancreatic ductal adenocarcinoma.
Ther Adv Med Oncol
2023
34775073
Endometrial cancer may be part of the MUTYH-associated polyposis cancer spectrum.
Eur J Med Genet
2022
35768194
Cancer risk and tumour spectrum in 172 patients with a germline <i>SUFU</i> pathogenic variation: a collaborative study of the SIOPE Host Genome Working Group.
J Med Genet
2022
35398964
Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma.
Mol Oncol
2022
35398880
PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon.
Cancer Discov
2022
35697931
Breast carcinomas with osteoclast-like giant cells: a comprehensive clinico-pathological and molecular portrait and evidence of RANK-L expression.
Mod Pathol
2022
36446943
Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature
2022
36505864
<i>In vivo</i> efficacy assessment of the CDK4/6 inhibitor palbociclib and the PLK1 inhibitor volasertib in human chordoma xenografts.
Front Oncol
2022
36131014
Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature
2022
36033544
Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies.
Front Oncol
2022
36053791
Significant response to pralsetinib in a medullary thyroid cancer harboring double RET variants of unknown significance.
Eur Thyroid J
2022
34877752
Novel EWSR1::UBP1 fusion expands the spectrum of spindle cell rhabdomyosarcomas.
Genes Chromosomes Cancer
2022
35174661
Intra- and extra-cranial BCOR-ITD tumours are separate entities within the BCOR-rearranged family.
J Pathol Clin Res
2022
35326637
Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in <i>PBRM1</i>-Mutated Human Chordoma Xenograft.
Cancers (Basel)
2022
35199222
Immunohistochemistry as a tool to identify ELP1-associated medulloblastoma.
Acta Neuropathol
2022
35164878
High-grade childhood intra-parenchymal brain tumor clustering with ATRT and expanding the cancer spectrum related to inherited SMARCE1 truncating variations.
Acta Neuropathol Commun
2022
34613529
Atypical evolution of meningiomatosis after discontinuation of cyproterone acetate: clinical cases and histomolecular characterization.
Acta Neurochir (Wien)
2022
34460114
A malignant choroid plexus tumour with prevailing immature blastematous elements.
Neuropathol Appl Neurobiol
2022
34750678
Correction to: Atypical evolution of meningiomatosis after discontinuation of cyproterone acetate: clinical cases and histomolecular characterization.
Acta Neurochir (Wien)
2022
32750212
Fine-needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next-generation sequencing in cancer patients included in the SHIVA02 trial.
Mol Oncol
2021
33741928
The transcriptional landscape of Shh medulloblastoma.
Nat Commun
2021
34994599
Hyperprogressive Disease After Pembrolizumab Treatment in Advanced Epstein-Barr Virus-Associated Gastric Adenocarcinoma With ERBB2 Amplification.
JCO Precis Oncol
2021
34541275
Tumor <i>BRCA</i> testing can reveal a high tumor mutational burden related to <i>POLE</i> pathogenic variants.
Gynecol Oncol Rep
2021
34717763
CNS tumors with YWHAE:NUTM2 and KDM2B-fusions present molecular similarities to extra-CNS tumors having BCOR internal tandem duplication or alternative fusions.
Acta Neuropathol Commun
2021
34151521
A novel case of cribriform neuroepithelial tumor: A potential diagnostic pitfall in the ventricular system.
Pediatr Blood Cancer
2021
34118772
Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery.
ESMO Open
2021
33999421
SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type.
J Pathol
2021
33377141
Prognostic relevance of clinical and molecular risk factors in children with high-risk medulloblastoma treated in the phase II trial PNET HR+5.
Neuro Oncol
2021
33331994
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
Acta Neuropathol
2021
1 - 50 of 107
Column Actions
Search
Recommended Authors
Hiroko Tanaka
Tokyo Medical and Dental University
Career Start Year
2012
Number of shared co-authors
2
Natalie J??ger
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year
2010
Number of shared co-authors
69
Jianling Ji
Children's Hospital Los Angeles
Career Start Year
2009
Number of shared co-authors
2
Catherine E Cottrell
Nationwide Children's Hospital
Career Start Year
2009
Number of shared co-authors
2
Malak Abedalthagafi
Emory School of Medicine
Career Start Year
2008
Number of shared co-authors
12
Pankaj Vats
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year
2008
Number of shared co-authors
2
Adrian M Dubuc
Dana-Farber Cancer Institute
Career Start Year
2008
Number of shared co-authors
70
Cristiane M Ida
Mayo Clinic Foundation
Career Start Year
2007
Number of shared co-authors
2
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
2005
Number of shared co-authors
0
Ann-Marie Patch
QIMR Berghofer Medical Research Institute
Career Start Year
2005
Number of shared co-authors
8
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year
2004
Number of shared co-authors
2
Angshumoy Roy
Texas Children's Hospital and Baylor College of Medicine
Career Start Year
2004
Number of shared co-authors
0
David A Solomon
University of California san francisco
Career Start Year
2003
Number of shared co-authors
42
Douglas R Stewart
Clinical Genetics Branch, National Cancer Institute
Career Start Year
2003
Number of shared co-authors
6
Marilyn M Li
Children's Hospital of Philadelphia
Career Start Year
2000
Number of shared co-authors
6
Piergiorgio Modena
S. Anna General Hospital
Career Start Year
2000
Number of shared co-authors
26
Lawrence J Jennings
Northwestern University Feinberg School of Medicine
Career Start Year
1998
Number of shared co-authors
2
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year
1998
Number of shared co-authors
3
Shashikant Kulkarni
Centene Center for Health Transformation, Centene Corporation
Career Start Year
1998
Number of shared co-authors
4
Carrie Sougnez
The Broad Institute of Harvard and MIT
Career Start Year
1998
Number of shared co-authors
7
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
1997
Number of shared co-authors
15
Donald W Parsons
Texas Children's Hospital
Career Start Year
1996
Number of shared co-authors
24
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Career Start Year
1995
Number of shared co-authors
13
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year
1995
Number of shared co-authors
1
Doris Steinemann
Hannover Medical School
Career Start Year
1994
Number of shared co-authors
9
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Career Start Year
1992
Number of shared co-authors
50
Julie M Gastier-Foster
Baylor College of Medicine
Career Start Year
1992
Number of shared co-authors
12
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year
1991
Number of shared co-authors
10
Mark J Routbort
University of Texas MD Anderson Cancer Center
Career Start Year
1989
Number of shared co-authors
2
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Career Start Year
1984
Number of shared co-authors
19
row(s) 1 - 30 of 30
Collaborators
Franck Bourdeaut
SIREDO Oncology Center, Institut Curie Hospital, and Universite de Paris
Co-authored papers
40
Olivier Delattre
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Co-authored papers
25
Ga??lle Pierron
Institut Curie Hospital
Co-authored papers
17
Pascale Varlet
Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM, University of Paris
Co-authored papers
11
Christelle Dufour
Universite Paris-Saclay
Co-authored papers
11
Olivier Ayrault
Institut Curie, PSL Research University, CNRS UMR, INSERM
Co-authored papers
10
Fran??ois Doz
Institut Curie and University Paris Cite
Co-authored papers
8
St??phanie Puget
Necker Hospital, Assistance Publique-Hopitaux de Paris
Co-authored papers
8
Mamy Andrianteranagna
INSERM U, Institut Curie, PSL Research University, Institut Curie Research Center
Co-authored papers
8
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
6
Paul Fr??neaux
Institut Curie
Co-authored papers
6
Michael D Taylor
The Hospital for Sick Children
Co-authored papers
6
Dominique Figarella-Branger
Co-authored papers
5
Delphine Guillemot
Institut Curie Hospital
Co-authored papers
5
Jean Soulier
University of Paris
Co-authored papers
5
Kevin Beccaria
Hopital Universitaire Necker-Enfants Malades
Co-authored papers
5
Anne Jouvet
Groupement Hospitalier EST, Universite de Lyon
Co-authored papers
4
David Malkin
Hospital for Sick Children
Co-authored papers
4
Celio Pouponnot
Institut Curie
Co-authored papers
4
Jennifer A Chan
Dana-Farber Cancer Institute
Co-authored papers
4
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers
4
Wies??awa Grajkowska
Children's Memorial Health Institute
Co-authored papers
4
Maria Luisa Garr??
DOPO Clinic and Neuroncology Unit, IRCCS Istituto Giannina Gaslini (IGG)
Co-authored papers
4
Vijay Ramaswamy
Hospital for Sick Children
Co-authored papers
4
Florence M G Cavalli
Institut Curie, PSL Research University
Co-authored papers
4
Franck Tirode
Cancer Center of Lyon
Co-authored papers
4
Didier Surdez
Balgrist University Hospital, University of Zurich (UZH)
Co-authored papers
4
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers
4
Ulrich Sch??ller
University Medical Center Hamburg-Eppendorf
Co-authored papers
4
Gudrun Schleiermacher
Institut Curie
Co-authored papers
3
1 - 30